July 5, 2022 09:16 AM EDTUpdated July 8, 02:21 AM

#BIO22: Fire­side Chat with John Car­roll & Stéphane Ban­cel; 'No­body needs the type of wealth that we have'

John Carroll

Editor & Founder

Dur­ing the big BIO con­fer­ence in San Diego last month, End­points News ed­i­tor John Car­roll sat down with Mod­er­na CEO Stéphane Ban­cel to dis­cuss the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times